首页> 外国专利> METHOD FOR ELIMINATING TYPICAL ATRIAL FLUTTER WHEN PERFORMING THORACOSCOPIC OPERATIONS AIMED AT TREATING ATRIAL FIBRILLATION

METHOD FOR ELIMINATING TYPICAL ATRIAL FLUTTER WHEN PERFORMING THORACOSCOPIC OPERATIONS AIMED AT TREATING ATRIAL FIBRILLATION

机译:进行房颤治疗中的胸腔镜手术时消除典型房颤的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, particularly to cardiovascular surgery. Guide director is inserted into the pericardial cavity along the diaphragmal heart surface anterior from the inferior vena cava. Ablation device is positioned so that its ends in area of their connection with guide directors are located at the level of right pulmonary vein mouths. Jaws of the ablation device is directed to the area of the Waterston furrow and the adjoining wall of the right atrium by arched side. Jaws of the ablation device grasp the wall of the right atrium together with the epicardial cellular membrane of the Waterston furrow. Fenestrated forceps are used to grip and pull a wall of the right atrium into the space between open jaws of the ablation device. Radio-frequency exposure is applied. Transmittance damage is achieved. Ablation device is removed from right pleural cavity. Ends of ablation device are disconnected from Guide directors located in transverse and oblique sinuses of pericardium. Ends of the ablation device are connected to a guide director positioned in an oblique sinus of the pericardium posterior to the inferior vena cava, and with a guide director located along the diaphragmal heart surface anterior to the inferior vena cava. Concave part of the jaws of the ablation device is directed towards the diaphragm. Then, guide directors are used to grip myocardium of right atrium with jaws of ablation device. Grip line is 1–2 cm distal to the inferior vena cava mouth; radio-frequency exposure is applied. Transmurality of damage is achieved.;EFFECT: method enables eliminating typical atrial flutter when performing thoracoscopic operations aimed at treating atrial fibrillation, reducing the number of postoperative complications in the form of supraventricular arrhythmias, besides, there is no need for a second stage of surgical management – in endovascular destruction of the cava-tricuspid neck.;1 cl, 1 ex
机译:技术领域本发明涉及医学,尤其涉及心血管外科。引导导向器沿着下腔静脉前方的the肌心脏表面插入心包腔。消融设备的位置应使其与引导导向器连接的区域的末端位于右肺静脉口的水平。消融装置的钳口通过拱形侧面指向沃特斯顿fur沟和右心房的邻接壁区域。消融器械的下颌与沃特斯顿fur沟的心外膜细胞膜一起抓住右心房壁。穿孔镊子用于将右心房壁抓紧并拉入消融装置张开钳口之间的空间。施加射频曝光。达到透光率损坏。从右胸膜腔移除消融装置。消融装置的末端与位于心包横窦和斜窦中的导向器断开连接。消融装置的端部连接至位于下腔静脉后方心包斜窦中的导向器,并沿下腔静脉前部的diaphragm肌心脏表面定位导向器。消融装置的钳口的凹形部分指向隔膜。然后,使用导向器通过消融装置的钳口夹住右心房心肌。握线位于下腔静脉口的远端1-2 cm;进行射频曝光。效果达到透湿性;效果:该方法可在进行旨在治疗房颤的胸腔镜手术时消除典型的房扑,减少以室上性心律失常为形式的术后并发症的数量,此外,无需进行第二阶段的手术处理–腔内三头颈部的血管内破坏。; 1 cl,1 ex

著录项

  • 公开/公告号RU2703847C1

    专利类型

  • 公开/公告日2019-10-22

    原文格式PDF

  • 申请/专利权人 VACHEV SERGEJ ALEKSEEVICH;

    申请/专利号RU20180140756

  • 发明设计人 VACHEV SERGEJ ALEKSEEVICH (RU);

    申请日2018-11-19

  • 分类号A61B18/02;

  • 国家 RU

  • 入库时间 2022-08-21 11:45:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号